The global yeast beta-glucan market revenue was around US$ 165 million in 2022 and is estimated to reach US$ 373.4 million by 2031, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period from 2023 to 2031.
Yeast beta-glucan is a polysaccharide that interacts with immune cells to enhance the body's immunological responses. Yeast beta-glucan has been regarded as a desirable food ingredient due to its multiple health advantages, including its capacity to lower cholesterol, aid in the reduction of cholesterol, and enhance gut health.
Market Driving Factors
The surge in demand for natural and organic foods products boosts the market growth. Consumers are becoming more health-conscious and are looking for natural and sufficient ways to enhance their health. Yeast beta-glucan is a natural ingredient that is effective in promoting wellness and health, making it a popular choice among consumers. For instance, Kellogg Company, an American multinational food manufacturing company, introduced a new line of cereals containing beta-glucan sourced from barley and oats to meet the increasing demand for natural and healthy food products.
Increasing Applications in the pharmaceutical industry boosts the market growth. Yeast beta-glucan has been shown to have the possibility in the treatment of several diseases, like diabetes, cancer, and cardiovascular diseases. As a result, there is an increasing demand for yeast beta-glucan in the pharmaceutical industry. For instance, Imugene Limited, a clinical-stage immuno-oncology company, launched the initiation of a Phase 1b clinical study of its HER-Vaxx cancer vaccine that contains yeast beta-glucan as an adjuvant.
High extraction costs related to production methods hamper the market growth.
Regional Analysis
Asia Pacific is expected to dominate the market in terms of revenue. This is due to the rise in meat and food consumption in densely populated areas. Furthermore, increasing awareness of the product's health benefits has enabled its use in a variety of therapeutic purposes in key nations, such as China, Japan, and India, which boosts regional revenue. For instance, a clinical study reported in BMJ Neurology discovered that children with autism spectrum disorder exhibited enhanced behavior and understanding ability after consuming yeast beta-glucan.
Segmentation Insights
Form Insight
The soluble segment dominates the market in terms of the CAGR over the forecast period. Changing lifestyles and the increasing popularity of premium beers worldwide are fueling the utilization of soluble yeast for fermentation in beer production. For instance, the EU Member States produced 33.1 billion liters of alcoholic beer and about 1.7 billion liters of beer with less than 0.5% alcohol and no alcohol.
Application Insight
The animal feed segment dominates the market in terms of revenue over the forecast period. This is due to the product's low cost. Improved immunological state in animals, enhanced antibody titers following vaccination, and surge resistance against microbial diseases are among the primary advantages of this segment.
The food and beverage segment dominated the market and is estimated to continue its dominance over the forecast period. This can be attributed to the increased usage of functional foods and dietary supplements around the world which would benefit the segment growth.
Prominent Companies
Segmentation Outline
The global yeast beta-glucan market segmentation focuses on Form, Purity, Application, and Region.
By Form
By Purity
By Application
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL YEAST BETA-GLUCAN MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: YEAST BETA-GLUCAN MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL YEAST BETA-GLUCAN MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL YEAST BETA-GLUCAN MARKET, BY FORM
5.1 OVERVIEW
5.2 SOLUBLE
5.3 INSOLUBLE
6 GLOBAL YEAST BETA-GLUCAN MARKET, BY PURITY
6.1 OVERVIEW
6.2 BELOW 70%
6.3 70%
6.4 70% TO 85%
6.5 ABOVE 85%
7 GLOBAL YEAST BETA-GLUCAN MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 FOOD & BEVERAGES
7.3 COSMETICS
7.4 PHARMACEUTICAL
7.5 ANIMAL FEED
8 GLOBAL YEAST BETA-GLUCAN MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL YEAST BETA-GLUCAN MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 ANGEL YEAST CO. LTD
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 KERRY GROUP
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 OHLY
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 MITUSHI BIOPHARMA
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 ARIA INGREDIENTS
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 BIORIGIN
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 VW INGREDIENTS
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 LALLEMAND AND LEIBER
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
著作権 ©2022 無断複写・転載を禁じます
